Scutari Rossana, Piermatteo Lorenzo, Ciancio Manuelli Matteo, Iannetta Marco, Salpini Romina, Bertoli Ada, Alteri Claudia, Saccomandi Patrizia, Bellocchi Maria Concetta, Malagnino Vincenzo, Teti Elisabetta, Sforza Daniele, Siragusa Leandro, Grande Michele, Sarmati Loredana, Svicher Valentina, Andreoni Massimo, Ceccherini-Silberstein Francesca
Department of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Surgical Emergency Unit, Emergency Department, Polyclinic Tor Vergata Foundation, 00133 Rome, Italy.
Life (Basel). 2020 Nov 23;10(11):302. doi: 10.3390/life10110302.
Our study aimed to investigate the kinetics of SARS-CoV-2 RNA in bile and in different body fluids of two SARS-CoV-2 positive patients with acute cholecystitis by innovative droplet digital PCR (ddPCR) assays. For each patient, nasopharyngeal- and rectal swabs, bile, urine, and plasma samples were collected at different time points for SARS-CoV-2 RNA quantification by two ddPCR assays. For both patients, ddPCR revealed persistent and prolonged detection of viral RNA in the nasopharyngeal swab despite triple-negative or single-positive results by qRT-PCR. In Patient 1, SARS-CoV-2 RNA dropped more rapidly in bile and rectal-swab and declined slowly in nasopharyngeal swab and plasma, becoming undetectable in all compartments 97 days after symptoms started. Conversely, in patient 2, SARS-CoV-2 RNA was detected, even if at low copies, in all body samples (with the exception of urine) up to 75 days after the onset of symptoms. This study highlights that SARS-CoV-2 RNA can persist for a prolonged time in respiratory samples and in several biological samples despite negativity to qRT-PCR, supporting SARS-CoV-2's ability to provoke persistent and disseminated infection and therefore to contribute to extra-pulmonary clinical manifestations.
我们的研究旨在通过创新的液滴数字PCR(ddPCR)检测方法,研究两名患有急性胆囊炎的SARS-CoV-2阳性患者胆汁及不同体液中SARS-CoV-2 RNA的动力学。对于每位患者,在不同时间点采集鼻咽拭子、直肠拭子、胆汁、尿液和血浆样本,通过两种ddPCR检测方法对SARS-CoV-2 RNA进行定量。对于两名患者,尽管qRT-PCR检测结果为三阴性或单阳性,但ddPCR显示鼻咽拭子中病毒RNA持续且长时间被检测到。在患者1中,SARS-CoV-2 RNA在胆汁和直肠拭子中下降更快,在鼻咽拭子和血浆中下降缓慢,症状开始97天后在所有样本中均无法检测到。相反,在患者2中,症状出现后75天内,所有身体样本(尿液除外)中均检测到SARS-CoV-2 RNA,即使拷贝数较低。这项研究表明,尽管qRT-PCR检测呈阴性,但SARS-CoV-2 RNA可在呼吸道样本和多种生物样本中长时间持续存在,支持SARS-CoV-2引发持续性和播散性感染并导致肺外临床表现的能力。